Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Melanoma 146Carcinoma, Non-Small-Cell Lung 112Carcinoma, Renal Cell 74Neoplasm Metastasis 53Carcinoma, Hepatocellular 51Squamous Cell Carcinoma of Head and Neck 50Lung Neoplasms 48Colorectal Neoplasms 34Pancreatic Neoplasms 30Neoplasms 30Hodgkin Disease 30Urinary Bladder Neoplasms 24Sarcoma 23Brain Neoplasms 23Stomach Neoplasms 22Head and Neck Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Carcinoma, Transitional Cell 20Glioblastoma 19Recurrence 17Colonic Neoplasms 17Kidney Neoplasms 16Uveal Melanoma 15Small Cell Lung Carcinoma 15Multiple Myeloma 15Esophageal Neoplasms 15Carcinoma, Squamous Cell 14Skin Neoplasms 13Leukemia, Myeloid, Acute 13

Interventions

Temozolomide 10Radiotherapy 10Bevacizumab 6Everolimus 5ribociclib 3Radiation 3Panobinostat 3Dasatinib 3Valproic Acid 2TIC10 compound 2Re-Irradiation 2Nivolumab 2Mebendazole 2Irinotecan 2Gemcitabine 2GDC-0084 2Etoposide 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cyclophosphamide 2Cilengitide 2Cetuximab 2vandetanib 1tovorafenib 1temsirolimus 1spartalizumab 1sargramostim 1reolysin 1pembrolizumab 1ovex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diffuse Intrinsic Pontine Glioma × Nivolumab × Clear all
NCT06639607 2026-06-03

PRiME II

Washington University School of Medicine

Phase 1/2 Not yet recruiting
68 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT02960230 2025-01-22

H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas

University of California, San Francisco

Phase 1/2 Completed
50 enrolled 12 charts
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡